#tocilizumab hashtag - Bluesky

@ginitaivas.bsky.social

2 weeks ago

University of Leicester trial hopes to find first licensed drug for Long Covid - Leicestershire Press The University of Leicester is now running a clinical trial in an attempt to find the first licensed drug that can be used as a treatment for this

Leicesterin yliopiston tutkimuksessa toivotaan löydettävän ensimmäinen hyväksytty lääke #LongCovid iin ???🧐

Tutkimus päätösvaiheeseen 12/2025, ja tulosten odotetaan olevan saatavilla 31. heinäkuuta 2026 mennessä.

#Tosilitsumabi #Tocilizumab #Korona #Covid19
leicestershirepress.com/2026/03/18/u...

1 0 0 0

@hemehub.bsky.social

1 month ago

🩸Facts about Multiple Myeloma:

Adverse Events and Management

#CRS #ICANS #Neurotoxicity #Neutropenia #Teclistamab #MajesTEC3 #Immunotherapy #Tocilizumab #Hematology #RareDiseases #BloodDisorders #ClinicalInsights #MedEd #HEMEHUB

1 0 0 0

Róża Przanowska

@rprzanowska.bsky.social

2 months ago

What happens when two postdocs connected through an amazing #NCI #F99K00 grant program, really like working together? You get a paper we are truly proud of - now live on bioRxiv!
#BreastCancerResearch #CancerBiology #TranslationalResearch #NCI #IL6 #Tocilizumab #Docetaxel #Organoids #UVA #UVABME

2 1 1 0

Respirology Case Reports

@respcasereports.bsky.social

5 months ago

A Case of #Steroid-Dependent #ImmuneCheckpointInhibitor Pneumonitis Treated With Subcutaneous #Tocilizumab
onlinelibrary.wiley.com/doi/10.1002/...

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

6 months ago

Celltrion's AVTOZMA®: A New Era for IV Treatments in the US Market Celltrion has launched AVTOZMA®, an intravenous formulation of tocilizumab-anoh, approved for treating various immunological conditions, expanding options for patients and physicians.

Celltrion's AVTOZMA®: A New Era for IV Treatments in the US Market #United_States #Incheon #Celltrion #AVTOZMA® #Tocilizumab

0 0 0 0

40:40 Recruitment - celia@4040recruitment.co.uk

@4040rec.bsky.social

7 months ago

Stada revives talk of an IPO – if conditions improve Germany's Stada has said it may make another attempt to seek a public listing in the autumn, after delaying its plans earlier this year.

#Stada #IPO #pharmaindustry #generics #OTC #specialtymedicines #rarediseases #chronicdiseases #biosimilars #plaquepsoriasis #psoriaticarthritis #Crohnsdisease #specialtybiosimilars #aflibercept #denosumab #golimumab #tocilizumab #blockbusterdrugs #GLP1agonists #diabetes #obesity
zurl.co/nbsw4

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

7 months ago

Bio-Thera and STADA Strengthen Biosimilar Partnership for Tocilizumab Immunotherapy Bio-Thera and STADA extend their collaboration in biosimilars with tocilizumab targeting inflammatory disorders. This alliance enhances patient access to treatment.

Bio-Thera and STADA Strengthen Biosimilar Partnership for Tocilizumab Immunotherapy #China #Guangzhou #Bio-Thera #STADA #Tocilizumab

0 0 0 0

@jyves94.bsky.social

8 months ago

FDA Expands Approval for Tocilizumab Biosimilar to Treat CRS FDA expands tocilizumab-anoh's indication for treating cytokine release syndrome, enhancing treatment options for patients undergoing CAR T-cell therapy.

La #FDA des USA a approuvé une indication élargie du #Tocilizumab (#Avtozma), un #Biosimilaire du #Tocilizumab ( #Actemra), pour le traitement du syndrome de libération de #Cytokines ( #SRC) chez les adultes et les patients pédiatriques âgés de 2 ans et plus.
www.targetedonc.com/view/fda-exp...

1 0 0 0

TRAstonDrs

@castltrastondrs.bsky.social

9 months ago

#Medsky🧪 #IDsky #pharmasky #Publichealth This IPDMA of RCTs in adults admitted to 🏥 due to #COVID, #JAKinhibitors reduced mortality across all levels of respiratory support, independent of #dexamethasone or #tocilizumab & probably decreased serious & severe adverse events vs with no JAK inhibitors.

1 0 1 0

Springer Medicine

@springermedicine.com

9 months ago

Precision Over Prednisone: Innovative Treatment Strategies for Giant Cell Arteritis Tocilizumab has emerged as a promising treatment option for giant cell arteritis, demonstrating significant potential to reduce glucocorticoid dependence. But unanswered questions remain, such as the…

#Tocilizumab has emerged as a promising treatment option for giant cell #arteritis, demonstrating significant potential to reduce glucocorticoid dependence. But unanswered questions remain.

Find out more in this #EdsChoice review 👉 buff.ly/Vnm4kN9

#RheumSky #MedSky

0 0 0 0

The Journal of Rheumatology

@jrheumatol.bsky.social

1 year ago

Research Article

Tocilizumab (TCZ) for Giant Cell Arteritis: Clinical Outcomes Following Relapses and TCZ Discontinuation Due to Adverse Events

📖 www.jrheum.org/cgi/content/...

#giantcellarteritis #vasculitis #glucocorticoids #tocilizumab

0 0 0 0

The Journal of Rheumatology

@jrheumatol.bsky.social

1 year ago

Editorial

Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events

📖 www.jrheum.org/cgi/content/...

#giantcellarteritis #tocilizumab

0 0 0 0

RHUMATOS.fr

@rhumatosfr.bsky.social

1 year ago

Risque de cancer au cours de la polyarthrite rhumatoïde - Rhumatos Risque par rapport à la population générale et associé aux traitements Le cancer, première cause de mortalité en France, touche particulièrement les patients atteints de polyarthrite rhumatoïde (PR), ...

🧐Le risque de #cancer est-il plus élevé dans la #PR ? La réponse dans le dernier Rhumatos

👉 rhumatos.fr/risque-de-ca...

#AntiTNP #abatacept #JAKi #tocilizumab #ritixumab

2 0 0 0

Autoimmune🦋

@autoimmuneaware.bsky.social

1 year ago

Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice - PubMed In this series, GCA relapses were observed in 15 % of patients, all of them non-severe. Relapses were associated with TCZ therapeutic schedule, such as IV administration, optimization, delayed initiat...

Relapses in giant cell arteritis treated with #tocilizumab. Retrospective multicenter study of 407 patients in clinical practice

pubmed.ncbi.nlm.nih.gov/39899915/

2 0 0 0

haysamrady

@sodatroubles.bsky.social

1 year ago

Daratumumab followed by tocilizumab for treatment of late antibody-mediated rejection in renal transplant recipients with high or moderate levels of de novo donor-specific antibodies: a pilot study - ... Background Effective treatment of late antibody-mediated rejection (late AMR) is still an unmet medical need. Clearing donor-specific antibody (DSA) and preventing its rebound is the ideal goal of tre...

#Daratumumab followed by #tocilizumab for treatment of late antibody-mediated rejection in #renal transplant recipients with high or moderate levels of de novo donor-specific antibodies: a pilot study
#nephsky

bmcnephrol.biomedcentral.com/articles/10....

4 0 0 0

TRAstonDrs

@castltrastondrs.bsky.social

1 year ago

Tocilizumab reduces hypercoagulation in COVID-19 – Perspectives from the coagulation and immunomodulation Covid assessment (Coag-ImmCovA) clinical trial Despite medical interventions, COVID-19 continues to persist at pandemic proportions. A hypercoagulation state was rapidly observed in the severely il…

This finding underscores the significance of #tocilizumab as a viable treatment option in severe #COVID cases, with the potential to decrease #thrombosis incidence.

www.sciencedirect.com/science/arti...

0 0 0 0

TRAstonDrs

@castltrastondrs.bsky.social

1 year ago

Highlights

#Tocilizumab treatment demonstrated a significant reduction of #hypercoagulation in hospitalized #COVID19 patients, by improvements in both global #coagulation tests & conventional laboratory tests, in comparison with anakinra or SC alone.

1 1 1 0

TRAstonDrs

@castltrastondrs.bsky.social

1 year ago

#MedSky🧪#IDSky #ICU #Tocilizumab treatment demonstrated a significant reduction of #hypercoagulation in hospitalized #COVID19 patients, by improvements in both global coagulation tests and conventional laboratory tests, in comparison with anakinra or SC alone.